"Very lame and imperfect theories are sufficient to suggest useful experiments which serve to correct those theories and give birth to others more perfect. These, then occasion farther experiments ...
Cyclooxygenase-2 (COX-2) is overexpressed in lung cancer, especially in adenocarcinoma (ADC). Our aim was to determine the prognostic value of COX-2 on survival in patients with lung cancer. Studies ...
The alternative text for this image may have been generated using AI. In invasive breast cancer, COX-2 expression has been shown to correlate with the levels of angiogenesis (measured by CD-31 ...
This issue of examines interventions aimed at improvingdrug safety. 1-4 The need for a rigorous researchagenda in pharmaceutical safety is highlighted byMerck's ...
Researchers have few tools for understanding what happens in the brain at the earliest stages of neuroinflammatory disorders such as Alzheimer’s or Huntington’s disease. A new signaling molecule that ...
COX-2 selective inhibitor is a form of Non-steroidal anti-inflammatory drug (NSAID) that directly targets COX-2, an enzyme responsible for inflammation and pain. Selectivity for COX-2 reduces the risk ...
Ferroptosis plays an essential role in chronic liver diseases, and cyclooxygenase-2 (COX-2) affects liver fibrosis through multiple mechanisms. However, research on COX-2 regulation of ferroptosis in ...
NEW ORLEANS, LA—Ten years in the making, with more than two out of three patients dropping out of the study, the PRECISION trial has found that the COX-2 inhibitor celecoxib is as safe—from a ...
The first patient was a 69-year-old man with no history of asthma or atopic disorders who had several episodes of exanthema during treatment with nonselective NSAIDs (ibuprofen, aspirin, diclofenac, ...
Regular use of aspirin reduces the risk of a colorectal neoplasm, but the mechanism by which aspirin affects carcinogenesis in the colon is not well understood. During 2,446,431 person-years of follow ...
BAE: Bovine aortic endothelial; RHP: Recombinant human protein. NSAIDs variably inhibit prostaglandin H synthase (COX). COX-2 was cloned in 1991, and it was subsequently established that COX-1 does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results